- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
The PAN Foundation Opens Atopic Dermatitis Patient Assistance Fund
The PAN Foundation today opened a new patient assistance program for people living with atopic dermatitis. Atopic dermatitis, also known as eczema, is an itchy inflammation of the skin. It is a chronic disease that affects the integumentary system.
The PAN Foundation today opened a new patient assistance program for people living with atopic dermatitis. Atopic dermatitis, also known as eczema, is an itchy inflammation of the skin. It is a chronic disease that affects the integumentary system.
According to the National Eczema Association, more than 18 million Americans have atopic dermatitis. Qualifying patients are eligible to receive grants from PAN to pay for the deductibles, co-pays and coinsurance costs associated with their atopic dermatitis treatment.
“Thanks to our generous donors, we’re pleased to offer financial assistance for patients living with atopic dermatitis,” said PAN President and CEO Daniel Klein. “The cost of paying for care should never prevent someone from getting treatment for this serious and chronic condition. By receiving financial assistance, patients can focus on improving their health and overall quality of life.”
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Age Alone Is No Barrier to Allo-HCT for AML, Data Indicate
April 17th 2024A new study is among the largest real-world analyses to date to assess trends over time and predictive factors for older patients with acute myeloid leukemia (AML) who received allogeneic hematopoietic cell transplantation (allo-HCT).
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Need for Pharmacogenomic Testing in Mental Health Care Explored at AMCP 2024
April 17th 2024Presenters from Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Read More
